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This Month in the Journal
For those of us without a statistical background, gene-
mapping methods can sometimes be perplexing. To un-
ravel their mysteries, we present two invited editorials.
The first, by Dale Nyholt (p. 282), explains the statistical
properties of the most popular linkage analysis tech-
niques, with particular emphasis on the variability in the
significance of a LOD score, depending on the technique
that is used. Next, Jurg Ott and Josephine Hoh (p. 289)
provide an overview of statistical methods for both gene
mapping and the analysis of microarray data.
Our next two invited editorials provide commentary
on articles that are included in this issue. Abel and Ca-
sanova (p. 274) discuss the finding, by Greenwood et
al. (p. 405), of a tuberculosis-susceptibility locus. They
speculate on the likely spectrum of genetic control for
tuberculosis and on the ramifications of this finding. The
next editorial is by Folstein andMankoski (p. 278), who
pull together the results presented by Lai et al. (p. 357)
and Vincent et al. (p. 510). The Vincent et al. article
reveals a gene, termed “RAY1,” that is interrupted by
a translocation breakpoint on chromosome 7q31 in a
patient with autism. On an overlapping region of 7q31
is SPCH1, which is associated with a severe disorder of
speech and language and which, through work by Lai
et al., has been narrowed to ∼6 Mb. Folstein and Man-
koski discuss the possibility that a single gene could be
involved in both autism and the speech and language
disorder.
Analysis of SNPs around APOE, by Martin et al.
(p. 383)
The use of single-nucleotide polymorphisms (SNPs) as
markers for genetic mapping has been touted as thewave
of the future, and large initiatives with the aim of iden-
tifying hundreds of thousands of SNPs are currently un-
der way. But how effective will SNPs be in identifying
the genes involved in complex disorders? Eden Martin
and colleagues (p. 383) have performed a study designed
to examine this problem, using APOE as a model locus.
APOE is a well-established susceptibility gene for late-
onset Alzheimer disease. Using 60 SNPs surrounding
APOE, in both case-control and family-based analyses,
the authors have attempted to collect evidence for as-
sociation between Alzheimer disease and the already-
identified locus. Not only do their results demonstrate
that associations can be detected at SNPs near a complex
disease gene, but they also suggest how SNPs can be
more effectively utilized in this type of analysis. These
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suggestions include the use of a high density of SNPs
and the incorporation of haplotype analysis, which can
yield more-significant results than are provided by sin-
gle-locus tests. Interestingly, there were SNPs in APOE
that were not highly associated with Alzheimer disease,
as well as SNPs in a neighboring gene that did show
strong association with the disease. These results high-
light the difficulties in definitively identifying the gene
associated with a disorder, even when the general genetic
region of interest is known, and emphasize the need for
a multidisciplinary approach to gene identification. This
study will no doubt be very useful as a model for SNP-
based association studies of complex disease.
Trisomic Pregnancy and Menopause, by Kline et al.
(p. 395)
The increased risk of autosomal trisomy with advancing
maternal age has long been recognized but not under-
stood. Dorothy Warburton has hypothesized that this
increased risk is due to depletion of the oocyte pool in
older women. This hypothesis, which is tested by War-
burton and colleagues in this issue of the Journal, pre-
dicts that women who have had trisomic pregnancies
will undergo menopause at an earlier age, since meno-
pause occurs when the oocyte pool drops below a certain
level. In their study sample, Kline et al. found that
women whose index pregnancy was a trisomic sponta-
neous abortion had a lower median age at menopause
than did women whose index pregnancy was a chro-
mosomally normal birth or loss. These results fit very
nicely with those of a recent Journal Report by Freeman
et al. (66:1680–1683 [cited by Kline et al.]), who found
that women who have either a congenital or surgical
loss of an ovary are at an increased risk for a child with
Down syndrome (trisomy 21). Both papers are consis-
tent with an association between diminished oocyte
pools and trisomic pregnancies and provide support for
the Warburton hypothesis that oocytes in a suboptimal
state of development can become the dominant follicle
in a diminished oocyte pool and that these suboptimal
oocytes are more likely to exhibit nondisjunction.
Chromosome 11 Melanoma Tumor–Suppressor Genes,
by Goldberg et al. (p. 417)
Although significant evidence exists for the presence of
multiple tumor-suppressor genes on chromosome 11,
it has been difficult to delineate the regions involved.
Previous research has focused on the identification of
homozygous deletions on this chromosome and has
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turned up only one such region, on chromosome
11q23. Goldberg et al. have reasoned that haploinsuf-
ficiency of a tumor-suppressor gene might provide a
growth advantage to tumor cells, and they have de-
signed a new mapping strategy based on this idea. This
method, termed “homozygosity mapping of deletions”
(HOMOD), uses the number of homozygous genotypes
observed at adjacent loci to determine the probability
that a hemizygous chromosomal deletion exists. These
researchers have examined melanoma cell lines for ex-
tended regions of homozygosity (i.e., homozygosity at
more than five adjacent markers) and have used these
data to define deletions. Loss of heterozygosity (LOH)
studies on melanoma samples were also performed,
and the results correlated very well with the regions
defined by HOMOD analysis. Together, the HOMOD
and LOH analyses identified six small regions of over-
lapping deletions that better defined the locations of
putative tumor-suppressor genes on chromosome 11.
HOMOD is a promising method for the further iden-
tification of tumor-suppressor genes in human cancers.
A High Frequency of HV1 Heteroplasmy, by Tully et
al. (p. 432)
As the only significant noncoding region in the mito-
chondrial genome, the HV1 locus has been used exten-
sively in studies of human evolution and population ge-
netics, as well as in forensic testing. Although the chance
of mtDNA heteroplasmy is high because there are hun-
dreds of copies of mtDNA per cell, a mixed population
of mtDNA has not often been observed. Tully et al. have
used a sensitive, denaturant gradient gel electrophoresis
method (DGGE) to measure the population incidence of
HV1 sequence heteroplasmy and have found that it oc-
curs in 13.8% of the individuals examined and at a
broad spectrum of sites within HV1. This level of het-
eroplasmy is much higher than that previously mea-
sured. Presumably, this is due to the fact that most het-
eroplasmic variants occurred at very low proportions
that could not be detected by earlier, less-sensitive meth-
ods. Accurate measurements of HV1 heteroplasmy, by
methods such as DGGE, should allow better estimations
of generational mutation rates in the mitochondrial ge-
nome, a calculation critical for evolutionary studies us-
ing mtDNA.
Report (ABCR Mutations in AMD), by Allikmets and
the International ABCR Screening Consortium (p. 487)
In a 1997 study, Rando Allikmets and colleagues pro-
vided evidence that heterozygous carriers of mutations
in ABCR are predisposed to age-related macular degen-
eration (AMD), a very common form of acquired visual
impairment in the elderly (see the References list pro-
vided in the article by Allikmets and the International
ABCR Screening Consortium). However, this association
has been controversial and difficult to corroborate. To
investigate further the relationship between ABCR mu-
tations and AMD, a large, multinational consortiumwas
established. The study presented, in this issue of the Jour-
nal, by the International ABCR Screening Consortium
was designed to eliminate some of the controversy of
previous studies, including arguments on population
stratification and on statistical corrections. More than
1,200 cases of AMD and a similar number of matched
controls were screened, in a masked fashion, for the
presence of two of the more common ABCR variants,
G1961E and D2177N. Carriers of D2177N and carriers
of G1961E were found to have three- and fivefold in-
creases in AMD risk, respectively. These data provide
substantial evidence for the association between ABCR
mutations and AMD. They are interesting for an addi-
tional reason: the G1961E and D2177Nmutations were
first identified in patients with Stargardt disease, a re-
cessively inherited degeneration of the macula of the ret-
ina, which has an early age at onset. The variants there-
fore lead to different phenotypes (including a strikingly
different age at onset) if they are in a homozygous or a
heterozygous state.
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